Education
About Us
Working with TipRanks
Follow Us
Organon (OGN)
NYSE:OGN
Total Valuation
Organon has a market cap or net worth of $2.13B. The enterprise value is $10.24B.
Market Cap$2.13B
Enterprise Value$10.24B
Share Statistics
Organon has 259,982,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding259,982,900
Owned by Insiders0.37%
Owned by Institutions0.58%
Financial Efficiency
Organon’s return on equity (ROE) is 1.83 and return on invested capital (ROIC) is 14.22%.
Return on Equity (ROE)1.83
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)14.22%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee640.30K
Profits Per Employee86.40K
Employee Count10,000
Asset Turnover0.49
Inventory Turnover2.03
Valuation Ratios
The current PE Ratio of Organon is 4.3. Organon’s PEG ratio is -0.27.
PE Ratio4.3
PS Ratio0.60
PB Ratio8.13
Price to Fair Value8.13
Price to FCF6.52
Price to Operating Cash Flow2.19
PEG Ratio-0.27
Income Statement
In the last 12 months, Organon had revenue of 6.40B and earned 864.00M in profits. Earnings per share was 3.36.
Revenue6.40B
Gross Profit3.71B
Operating Income1.49B
Pretax Income807.00M
Net Income864.00M
EBITDA1.60B
Earnings Per Share (EPS)3.36
Cash Flow
In the last 12 months, operating cash flow was 949.00M and capital expenditures -383.00M, giving a free cash flow of 566.00M billion.
Operating Cash Flow949.00M
Free Cash Flow566.00M
Free Cash Flow per Share2.18
Dividends & Yields
Organon pays an annual dividend of $0.02, resulting in a dividend yield of 4.8%
Dividend Per Share$0.02
Dividend Yield4.8%
Payout Ratio8.65%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change-45.07%
50-Day Moving Average7.80
200-Day Moving Average9.03
Relative Strength Index (RSI)42.37
Average Volume (3m)5.35M
Important Dates
Organon upcoming earnings date is Feb 12, 2026, Before Open (Confirmed).
Last Earnings DateNov 10, 2025
Next Earnings DateFeb 12, 2026
Ex-Dividend Date―
Financial Position
Organon as a current ratio of 1.60, with Debt / Equity ratio of 974.39%
Current Ratio1.60
Quick Ratio1.11
Debt to Market Cap2.33
Net Debt to EBITDA5.21
Interest Coverage Ratio2.86
Taxes
In the past 12 months, Organon has paid -57.00M in taxes.
Income Tax-57.00M
Effective Tax Rate-0.07
Enterprise Valuation
Organon EV to EBITDA ratio is 7.60, with an EV/FCF ratio of 20.74.
EV to Sales1.90
EV to EBITDA7.60
EV to Free Cash Flow20.74
EV to Operating Cash Flow12.99
Balance Sheet
Organon has $672.00M in cash and marketable securities with $8.83B in debt, giving a net cash position of -$8.16B billion.
Cash & Marketable Securities$672.00M
Total Debt$8.83B
Net Cash-$8.16B
Net Cash Per Share-$31.37
Tangible Book Value Per Share-$21.87
Margins
Gross margin is 55.04%, with operating margin of 23.21%, and net profit margin of 13.49%.
Gross Margin55.04%
Operating Margin23.21%
Pretax Margin12.60%
Net Profit Margin13.49%
EBITDA Margin25.05%
EBIT Margin20.72%
Analyst Forecast
The average price target for Organon is $9.38, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$9.38
Price Target Upside14.33% Upside
Analyst ConsensusModerate Sell
Analyst Count4
Revenue Growth Forecast-1.69%
EPS Growth Forecast-61.89%